Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Penis | 1 | 2018 | 101 | 0.69 | Why? |
| Venous Thrombosis | 10 | 2019 | 2739 | 0.66 | Why? |
| Leg | 1 | 2017 | 142 | 0.64 | Why? |
| Amputation | 1 | 2018 | 331 | 0.59 | Why? |
| Dabigatran | 1 | 2017 | 204 | 0.58 | Why? |
| Carcinoma | 1 | 2018 | 256 | 0.57 | Why? |
| Antithrombins | 1 | 2017 | 353 | 0.52 | Why? |
| Heart Injuries | 1 | 2020 | 608 | 0.52 | Why? |
| General Practitioners | 1 | 2017 | 568 | 0.41 | Why? |
| Pulmonary Embolism | 5 | 2021 | 4775 | 0.41 | Why? |
| Venous Thromboembolism | 5 | 2021 | 4273 | 0.39 | Why? |
| Fibrin Fibrinogen Degradation Products | 2 | 2021 | 5993 | 0.33 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.32 | Why? |
| Atrial Fibrillation | 2 | 2017 | 2320 | 0.30 | Why? |
| Palliative Care | 1 | 2021 | 2665 | 0.30 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.28 | Why? |
| Anticoagulants | 7 | 2021 | 9563 | 0.19 | Why? |
| Antidotes | 1 | 2017 | 46 | 0.17 | Why? |
| Natriuretic Peptides | 1 | 2018 | 66 | 0.17 | Why? |
| Italy | 7 | 2021 | 38444 | 0.17 | Why? |
| Hashimoto Disease | 1 | 2017 | 74 | 0.16 | Why? |
| Cerebral Veins | 1 | 2017 | 81 | 0.16 | Why? |
| Echocardiography, Doppler | 1 | 2018 | 269 | 0.15 | Why? |
| Neck Pain | 1 | 2017 | 126 | 0.15 | Why? |
| Fibrinolytic Agents | 2 | 2017 | 1702 | 0.14 | Why? |
| Internal Medicine | 1 | 2021 | 557 | 0.14 | Why? |
| Vitamin K | 1 | 2017 | 263 | 0.14 | Why? |
| Stroke | 2 | 2017 | 8839 | 0.14 | Why? |
| Self-Injurious Behavior | 1 | 2018 | 391 | 0.13 | Why? |
| Administration, Oral | 2 | 2017 | 2340 | 0.12 | Why? |
| Hemorrhage | 4 | 2017 | 3013 | 0.12 | Why? |
| Thyroid Gland | 1 | 2017 | 516 | 0.12 | Why? |
| Aged | 16 | 2021 | 215776 | 0.12 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.10 | Why? |
| Male | 17 | 2021 | 367725 | 0.10 | Why? |
| Atherosclerosis | 1 | 2017 | 768 | 0.09 | Why? |
| Humans | 26 | 2021 | 930598 | 0.09 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.09 | Why? |
| Heparin, Low-Molecular-Weight | 1 | 2017 | 1731 | 0.09 | Why? |
| Middle Aged | 13 | 2021 | 270681 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2021 | 3629 | 0.08 | Why? |
| Prospective Studies | 4 | 2020 | 43301 | 0.08 | Why? |
| Pharmacists | 1 | 2017 | 1246 | 0.08 | Why? |
| Electrocardiography | 1 | 2021 | 3957 | 0.08 | Why? |
| Female | 16 | 2021 | 380317 | 0.08 | Why? |
| Prognosis | 5 | 2021 | 32490 | 0.07 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.07 | Why? |
| Outpatients | 1 | 2018 | 3417 | 0.07 | Why? |
| Referral and Consultation | 1 | 2021 | 4816 | 0.07 | Why? |
| France | 1 | 2021 | 12074 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.07 | Why? |
| Sex Factors | 1 | 2021 | 11014 | 0.06 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.06 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.06 | Why? |
| Length of Stay | 1 | 2021 | 11042 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2021 | 6153 | 0.06 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.06 | Why? |
| Secondary Prevention | 2 | 2017 | 762 | 0.06 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.06 | Why? |
| Ultrasonography | 1 | 2017 | 4409 | 0.06 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.05 | Why? |
| Risk Assessment | 4 | 2018 | 25439 | 0.05 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.05 | Why? |
| Risk Factors | 6 | 2017 | 71621 | 0.05 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Recurrence | 2 | 2017 | 3675 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Perfusion | 1 | 2017 | 254 | 0.04 | Why? |
| Treatment Outcome | 3 | 2017 | 51732 | 0.04 | Why? |
| Adult | 5 | 2021 | 244371 | 0.04 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.03 | Why? |
| Diabetes Mellitus | 1 | 2017 | 8207 | 0.03 | Why? |
| Depression | 1 | 2018 | 14116 | 0.03 | Why? |
| Pharmacies | 1 | 2017 | 356 | 0.03 | Why? |
| Data Interpretation, Statistical | 1 | 2017 | 657 | 0.03 | Why? |
| Enoxaparin | 1 | 2017 | 1064 | 0.03 | Why? |
| Young Adult | 2 | 2017 | 93724 | 0.02 | Why? |
| Hemodynamics | 1 | 2018 | 1562 | 0.02 | Why? |
| Ventricular Dysfunction, Left | 1 | 2018 | 993 | 0.02 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.02 | Why? |
| Hypertension, Pulmonary | 1 | 2017 | 970 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2017 | 10649 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Geriatrics | 1 | 2017 | 947 | 0.02 | Why? |
| Prevalence | 2 | 2019 | 25773 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2017 | 53120 | 0.01 | Why? |
| Disease Management | 1 | 2017 | 6841 | 0.01 | Why? |
| Lung | 2 | 2018 | 31049 | 0.01 | Why? |
| Thrombosis | 1 | 2017 | 7504 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
Mumoli's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(106)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(56)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_